The regulation of lncRNA CADM2-AS1 on miR-5047 and NOTCH4 also existed in clinical tissues of GC with lymph node metastasis, which give lncRNA CADM2-AS1 the potential to a prognostic and predictive biomarker in treatment of metastatic GC. This evidence concerns the gene CADM2 and gastric cancer.